Baker Bros. Advisors as of June 30, 2011
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 21 positions in its portfolio as reported in the June 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| InterMune | 23.1 | $18M | 509k | 35.85 | |
| Medivation | 14.4 | $11M | 531k | 21.43 | |
| Ariad Pharmaceuticals | 11.3 | $8.9M | 785k | 11.33 | |
| BioMarin Pharmaceutical (BMRN) | 9.6 | $7.6M | 279k | 27.21 | |
| Anthera Pharmaceuticals | 9.3 | $7.4M | 900k | 8.17 | |
| ZIOPHARM Oncology | 6.6 | $5.2M | 850k | 6.12 | |
| Anacor Pharmaceuticals | 5.1 | $4.0M | 619k | 6.46 | |
| Inhibitex | 3.9 | $3.1M | 781k | 3.92 | |
| Idenix Pharmaceuticals | 3.6 | $2.9M | 573k | 5.00 | |
| Salix Pharmaceuticals | 3.3 | $2.6M | 66k | 39.82 | |
| Alkermes | 2.7 | $2.1M | 115k | 18.60 | |
| AVANIR Pharmaceuticals | 2.1 | $1.7M | 500k | 3.36 | |
| Xoma | 1.2 | $941k | 400k | 2.35 | |
| Ligand Pharmaceuticals | 1.1 | $877k | 73k | 11.95 | |
| Idera Pharmaceuticals | 0.8 | $620k | 288k | 2.15 | |
| Aegerion Pharmaceuticals | 0.8 | $613k | 39k | 15.76 | |
| Cumberland Pharmaceuticals (CPIX) | 0.7 | $554k | 96k | 5.75 | |
| Alere | 0.3 | $207k | 742.00 | 278.98 | |
| Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.1 | $84k | 21k | 4.00 | |
| Aradigm Corporation (ARDM) | 0.0 | $19k | 100k | 0.19 | |
| VIA Pharmaceuticals (VIAP) | 0.0 | $5.1k | 103k | 0.05 |
